This study aimed to identify prognostic factors in patients with metastatic uveal melanoma
(UM) that were associated with long-term survival in a real-world setting. A total of 94 …

Background Despite improvements in the treatment of primary uveal melanoma (UM),
patients with metastatic disease continue to exhibit poor survival. Methods A retrospective …

Simple Summary This retrospective multicenter study examines the influence of hepatic and
extrahepatic metastases on the response of immune checkpoint blockade (ICB) in patients …

Uveal melanoma (UM) is the most common primary intraocular tumor in adults. Up to 50% of
UM patients will develop metastases. We present data of 175 metastatic UM patients …

Simple Summary Uveal melanoma is a rare form of melanoma but is the most common
tumor in the eye. Despite having effective treatments for the initial tumor, many patients …

Background Uveal melanoma is an orphan malignancy with very limited data on treatment
options in metastatic setting. Methods In this single-center retrospective study, we describe …

Metastatic uveal melanoma (MUM) has a poor prognosis, with no established standard of
care. Delineation of prognostic factors in MUM patients may enable stratified treatment …

Background: To report the tumor, patient, and treatment characteristics of long-term
metastatic uveal melanoma survivors. Methods: A non-comparative, retrospective case …

The overall survival (OS) of patients with metastatic uveal melanoma is short, the evidence
for effectiveness of treatments is limited, and no consensus on the choice of treatment exists …

Background Uveal melanoma (UM) is an ocular malignancy with high potential for
metastatic spread. In contrast to cutaneous melanoma, immunotherapy has not yet shown …